TD Cowen Reiterates Buy Rating and Top Pick on Roivant Sciences (ROIV)

March 4, 2026 8:36 AM EST Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating and $38.00 price target on Roivant Sciences (NASDAQ: ROIV).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login